This one-hour, on-demand, journal article-based activity examines the risks associated with pregnancy and elective termination among females receiving treatment for substance use disorder (SUD) compared to those not in treatment.

This one-hour, on-demand, journal article-based activity examines findings from 22 published case reports on the effects of inhalant use during pregnancy. It explores the impact on maternal health, fetal development, neonatal outcomes, and early childhood.

This one-hour, on-demand, journal article-based activity presents original research on the prescribing of medications for alcohol use disorder (MAUD) among birthing people with an alcohol-related diagnosis. Although safety and effectiveness of medications for alcohol use disorder (MAUD) are generally well established for adults, the literature on its use in pregnancy is limited. To better understand the benefit and risks of medications for AUD in pregnancy, this study offers an analysis of insurance claim data to estimate the prevalence of birthing people currently receiving prescriptions for medications for alcohol use disorder.

This two-hour online course equips healthcare professionals with the essential knowledge, skills, and tools to effectively identify and treat women with substance use disorders (SUDs).

This 8-hour, online course provides the education that is essential for providers to identify, assess, diagnose, and manage pregnant and postpartum patients with opioid use disorder (OUD).

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This 30-minute, on-demand session from the ASAM 2024 Review Course discusses substance-related treatment for pregnant or post-partum patients and newborns.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the racial and socio-economic complexity behind laws governing drug use during pregnancy and be able to contextualize these laws with the use of Urine Drug Screen during pregnancy.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses treatment with Methadone split dose and 72hr dispensing, and how to support marginalized and structurally oppressed birthing people to make healthy choices and to engage in evidence-based services that secure access, equity, value-based caring and optimal outcomes.

This 88-hour on-demand conference includes 71 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.